Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions ; volume:10 ; number:1 ; day:10 ; month:7 ; year:2024 ; pages:1-9 ; date:12.2024
Cell death discovery ; 10, Heft 1 (10.7.2024), 1-9, 12.2024
- Urheber
-
Zhong, Yan
Liu, Jingfeng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41420-024-02077-1
- URN
-
urn:nbn:de:101:1-2409272104252.276387188382
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhong, Yan
- Liu, Jingfeng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
CAR-NK cells for cancer immunotherapy: from bench to bedside
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
Car-engineered nk cells for the treatment of glioblastoma: Turning innate effectors into precision tools for cancer immunotherapy
Kinase-targeted cancer therapies: progress, challenges and future directions
Emerging therapies for glioblastoma: current state and future directions
Advanced Acral Melanoma Therapies: Current Status and Future Directions
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
CAR-NK cells for cancer immunotherapy: from bench to bedside
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
Car-engineered nk cells for the treatment of glioblastoma: Turning innate effectors into precision tools for cancer immunotherapy
Kinase-targeted cancer therapies: progress, challenges and future directions
Emerging therapies for glioblastoma: current state and future directions
Advanced Acral Melanoma Therapies: Current Status and Future Directions
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
CAR-NK cells for cancer immunotherapy: from bench to bedside
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
Car-engineered nk cells for the treatment of glioblastoma: Turning innate effectors into precision tools for cancer immunotherapy
Kinase-targeted cancer therapies: progress, challenges and future directions
Emerging therapies for glioblastoma: current state and future directions